Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning
K-Number: K260324 · 2026-05-22
Device Summary
Frequently Asked Questions
What is the Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning?
Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning is a medical device that received FDA 510(k) clearance on 2026-05-22. The listed applicant is Canon Medical Informatics, Inc.. The 510(k) number is K260324.
When did Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning receive FDA 510(k) clearance?
Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning received FDA 510(k) clearance on 2026-05-22, under 510(k) number K260324.
Who is the listed applicant for Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning?
The FDA 510(k) record lists Canon Medical Informatics, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning?
The FDA product code for Vitrea CT Transcatheter Aortic Valve Replacement (TAVR) Planning is QIH.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related PubMed Literature
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Canon Medical Informatics, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: QIH)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.